scholarly journals Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis

2015 ◽  
Vol 14 (4) ◽  
pp. 19191-19202 ◽  
Author(s):  
P.L. Chen ◽  
W.T. Li ◽  
J. Wang ◽  
Y.D. Jiang ◽  
P. Wu ◽  
...  
2019 ◽  
Vol 74 (3) ◽  
pp. 251-256 ◽  
Author(s):  
Hailong Su ◽  
Guo Zhang

Background: The correlation between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and hepatocellular carcinoma (HCC) remains controversial. Objectives: We performed this study to better assess the relationship between MTHFR gene polymorphisms and the likelihood of HCC. Methods: A systematic research of PubMed, Medline, and Embase was performed to retrieve relevant articles. ORs and 95% CIs were calculated. Results: A total of 15 studies with 8,378 participants were analyzed. In overall analyses, a significant association with the likelihood of HCC was detected for the rs1801131 polymorphism with fixed-effect models (FEMs) in recessive comparison (p = 0.002, OR 0.62, 95% CI 0.43–0.82). However, no positive results were detected for the rs1801133 polymorphism in any comparison. Further subgroup analyses revealed that the rs1801131 polymorphism was significantly associated with the likelihood of HCC in Asians with both FEMs (recessive model: p < 0.0001, OR 0.42, 95% CI 0.29–0.62; allele model: p = 0.004, OR 1.20, 95% CI 1.06–1.35) and random-effect models (recessive model: p = 0.002, OR 0.47, 95% CI 0.29–0.75). Nevertheless, we failed to detect any significant correlation between the rs1801133 polymorphism and HCC. Conclusions: Our findings indicated that the rs1801131 polymorphism may serve as a genetic biomarker of HCC in Asians.


2020 ◽  
Vol 39 (8) ◽  
pp. 2267-2279 ◽  
Author(s):  
Zahra Bagheri-Hosseinabadi ◽  
Danyal Imani ◽  
Hassan Yousefi ◽  
Mitra Abbasifard

2020 ◽  
Vol 29 (8) ◽  
pp. 1001-1009
Author(s):  
Huifeng Li ◽  
Xiawei Fei ◽  
Yanting Shen ◽  
Zhenqi Wu

2018 ◽  
Vol 38 (6) ◽  
Author(s):  
Aiping Xu ◽  
Weiping Wang ◽  
Xiaolei Jiang

Background: We performed the present study to better elucidate the correlations of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms with the risk of congenital heart diseases (CHD). Methods: Eligible articles were searched in PubMed, Medline, Embase and CNKI. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to detect any potential associations of MTHFR and MTRR gene polymorphisms with CHD. Results: A total of 47 eligible studies were finally included in our meta-analysis. Our overall analyses suggested that MTRR rs1801394, MTRR rs1532268, MTHFR rs1801131 and MTHFR rs1801133 polymorphisms were all significantly associated with the risk of CHD in certain genetic models. Further subgroup analyses according to ethnicity of study participants demonstrated that the MTRR rs1801394 polymorphism was significantly correlated with the risk of CHD only in Asians, whereas MTRR rs1532268, MTHFR rs1801133 and MTHFR rs1801131 polymorphisms were significantly correlated with the risk of CHD in both Asians and Caucasians. Conclusions: Our findings indicated that MTRR rs1532268, MTHFR rs1801131 and MTHFR rs1801133 polymorphisms may affect the risk of CHD in Asians and Caucasians, while the MTRR rs1801394 polymorphism may only affect in risk of CHD in Asians.


2020 ◽  
Vol 89 ◽  
pp. 81-88 ◽  
Author(s):  
Bhaskar V.K.S. Lakkakula ◽  
Shubham Sengupta ◽  
Jayant Agrawal ◽  
Shivani Singh ◽  
Prachi Mendhey ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Hong Weng ◽  
Sheng Li ◽  
Jing-Yu Huang ◽  
Zi-Qi He ◽  
Xiang-Yu Meng ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document